Actively Recruiting
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
Led by KidSIM Simulation Program · Updated on 2025-09-05
240
Participants Needed
4
Research Sites
169 weeks
Total Duration
On this page
Sponsors
K
KidSIM Simulation Program
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 experience unusually high rates of critical illness that needs advanced airway management and intensive care unit admission. Bag-valve-mask (BVM) ventilation, endotracheal Intubation (ETI) and chest compressions are sometimes required for critically ill COVID-19 patients, and may contribute to a high risk of infection amongst Health Care Workers (HCW). To lessen HCW risk during high-risk procedures, a device called an aerosol box has been developed to place over the head of the patient, shielding the provider's face from virus droplets suspended in the air. The purpose of this research study is to better understand how particles disperse during AGMPs, more specifically during the provision of cardiopulmonary resuscitation (CPR). The project team hopes what is learned from the project can help inform infection control measures. This could help make changes to the clinical environment and make it safer for HCW's. The investigators intend to explore how an aerosol box performs in reducing contamination of HCW's who perform critical airway interventions during resuscitation events.
CONDITIONS
Official Title
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Airway provider must be an attending physician, fellow, or resident in adult or pediatric emergency medicine, pediatric intensive care, general pediatrics, or pediatric/adult anesthesia
- Airway provider must have Adult or Pediatric Advanced Life Support certification
- CPR provider can be an attending physician, resident, fellow, nurse, respiratory therapist, physician assistant, or health care aide
- CPR provider must have Basic Life Support or Adult or Pediatric Advanced Life Support certification
You will not qualify if you...
- Decline to provide informed consent
- Unable to perform tasks required of the role due to physical limitations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Department of Emergency Medicine, Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
Actively Recruiting
2
KidSIM, Alberta Children's Hospital
Calgary, Alberta, Canada, T3B6A8
Actively Recruiting
3
Department of Pediatrics, The Hospital for Sick Children
Toronto, Ontario, Canada
Actively Recruiting
4
Department of Pediatrics, CHU Sainte-Justine
Montreal, Quebec, Canada
Completed
Research Team
A
Adam Cheng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here